Evidence map›Paper›PMID 27168766›Full record

ArticleEpigenetics & chromatin2016

Distinct epigenetic features of differentiation-regulated replication origins.

Owen K Smith, RyanGuk Kim, Haiqing Fu, Melvenia M Martin, Chii Mei Lin, Koichi Utani, Ya Zhang, Anna B Marks, Marc Lalande, Stormy Chamberlain and 5 more

Open access · goldAbstract read
In one paragraph

Article in Epigenetics & chromatin, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. BEND3 safeguards pluripotency by repressing differentiation-associated genes.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Cellular Reprogramming-A Model for Melanoma Cellular Plasticity.International journal of molecular sciences · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Owen K SmithDNA Replication Group, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA.
RyanGuk KimIn Silico Solutions, Falls Church, VA 22033 USA.
Haiqing FuDNA Replication Group, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA.
Melvenia M MartinDNA Replication Group, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA.
Chii Mei LinDNA Replication Group, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA.
Koichi UtaniDNA Replication Group, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA.
Ya ZhangDNA Replication Group, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA.
Anna B MarksDNA Replication Group, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA.
Marc LalandeDepartment of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT 06032 USA.
Stormy ChamberlainDepartment of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT 06032 USA.
Maxwell W LibbrechtDepartment of Computer Science and Engineering, University of Washington, Seattle, WA 98195 USA.
Eric E BouhassiraDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461 USA.
Michael C RyanIn Silico Solutions, Falls Church, VA 22033 USA.
William S NobleDepartment of Computer Science and Engineering, University of Washington, Seattle, WA 98195 USA ; Department of Genome Sciences, University of Washington, Seattle, WA 98195 USA.
Mirit I AladjemDNA Replication Group, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA.
National Cancer Institute · USCenter for Cancer Research · USIn Silico Biosciences (United States) · USNational Institutes of Health · USUConn Health · USUniversity of Washington · USAlbert Einstein College of Medicine · US

Funding

Initiation of DNA Replication in Mammalian CellsZIABC010411 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ALADJEM, MIRIT · 2009 to 2025
$25.0M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
INITIATION OF DNA REPLICATION IN MAMMALIAN CELLSZ01BC010411 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ALADJEM, MIRIT · 2000 to 2008
$1.8M
Regulation of UBE3A genomic imprinting by tissue-specific alternative splicingR01HD068730 · NICHD · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI CHAMBERLAIN, STORMY JO · 2011 to 2015
$1.3M
Intramural NIH HHS Z01 BC010411Intramural NIH HHS ZIA BC010411NCATS NIH HHS UL1 TR001073NICHD NIH HHS R01 HD068730
6 · The paper itself

Abstract

backgroundEukaryotic genome duplication starts at discrete sequences (replication origins) that coordinate cell cycle progression, ensure genomic stability and modulate gene expression. Origins share some sequence features, but their activity also responds to changes in transcription and cellular differentiation status.

resultsTo identify chromatin states and histone modifications that locally mark replication origins, we profiled origin distributions in eight human cell lines representing embryonic and differentiated cell types. Consistent with a role of chromatin structure in determining origin activity, we found that cancer and non-cancer cells of similar lineages exhibited highly similar replication origin distributions. Surprisingly, our study revealed that DNase hypersensitivity, which often correlates with early replication at large-scale chromatin domains, did not emerge as a strong local determinant of origin activity. Instead, we found that two distinct sets of chromatin modifications exhibited strong local associations with two discrete groups of replication origins. The first origin group consisted of about 40,000 regions that actively initiated replication in all cell types and preferentially colocalized with unmethylated CpGs and with the euchromatin markers, H3K4me3 and H3K9Ac. The second group included origins that were consistently active in cells of a single type or lineage and preferentially colocalized with the heterochromatin marker, H3K9me3. Shared origins replicated throughout the S-phase of the cell cycle, whereas cell-type-specific origins preferentially replicated during late S-phase.

conclusionsThese observations are in line with the hypothesis that differentiation-associated changes in chromatin and gene expression affect the activation of specific replication origins.

Indexed as

Cell cycleCellular differentiationChromatinCpG islandsH3K4me3H3K9AcH3K9me3Histone modificationOrigin of replicationProliferation

Identifiers

PMID27168766
PMCPMC4862150
OpenAlexW2346104125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.